IDiyas

For the Inventor, By the Inventor

Valflaunes, France

Francis JeanJean

USPTO Granted Patents = 16

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 178(Granted Patents)


Company Filing History:

goldMedal16 out of 1,451 
 
Sanofi
 patents

Years Active: 1995-2001

Loading Chart...
16 patents (USPTO):Explore Patents
1. 6172239 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharamaceutical compositions containing them (2001-01-09),
2. 5965579 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-10-12),
3. 5939449 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-08-17),
4. 5936123 - Hydrazine derivative compounds as intermediates for preparing (1999-08-10),
5. 5925661 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-07-20),
6. 5744493 - 3-amidopyrazole derivatives and pharmaceutical compositions containing (1998-04-28),
7. 5744491 - 3-amidopyrazole derivatives, process for preparing these and (1998-04-28),
8. 5723483 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1998-03-03),
9. 5635526 - 3-amidopyrazole derivatives, process for preparing these and (1997-06-03),
10. 5616592 - 3-amidopyrazole derivatives, process for preparing these and (1997-04-01),
11. 5607958 - 3-amidopyrazole derivatives, process for preparing these and (1997-03-04),
12. 5585497 - Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on (1996-12-17),
13. 5561234 - 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, (1996-10-01),
14. 5523455 - Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on (1996-06-04),
15. 5502059 - Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on (1996-03-26),

Title: The Innovative Contributions of Francis JeanJean

Introduction

Francis JeanJean is a notable inventor based in Valflaunes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with neurotensin receptors. With a total of 16 patents to his name, JeanJean's work has had a considerable impact on medical research and drug development.

Latest Patents

One of his latest patents includes the invention of substituted 1-phenyl-3-pyrazolecarboxamides that are active on neurotensin receptors. This invention relates to compounds that exhibit a strong affinity for neurotensin receptors, which are crucial in various physiological processes. The pharmaceutical compositions containing these compounds have the potential to lead to new therapeutic options for various conditions.

Career Highlights

Francis JeanJean is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation. His extensive experience and dedication to research have positioned him as a key figure in his area of expertise.

Collaborations

Some of his notable coworkers include Robert Boigegrain and Danielle Gully. Their collaborative efforts have contributed to the advancement of research and development within the company, fostering an environment of innovation and discovery.

Conclusion

Francis JeanJean's innovative work in the pharmaceutical industry exemplifies the importance of research and development in creating new medical solutions. His contributions, particularly in the area of neurotensin receptor interactions, highlight the potential for advancements in therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…